Alvotech
(NASDAQ : ALVO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.54%170.180.7%$963.95m
ABBVAbbVie, Inc. 0.92%139.321.9%$835.67m
PFEPfizer Inc. 0.10%49.320.9%$825.93m
LLYEli Lilly & Co. 0.39%302.481.1%$749.06m
MRKMerck & Co., Inc. 1.16%88.420.7%$748.44m
BMYBristol-Myers Squibb Co. 1.87%73.471.0%$661.99m
SIGASIGA Technologies, Inc. -5.97%21.910.0%$388.23m
AZNAstraZeneca Plc -1.26%65.201.0%$376.67m
ALNYAlnylam Pharmaceuticals, Inc. 5.22%229.998.1%$253.86m
GSKGSK Plc -0.56%40.350.3%$216.68m
HZNPHorizon Therapeutics Plc 0.55%69.995.4%$198.90m
SGENSeagen Inc. 1.54%178.525.7%$191.65m
NVSNovartis AG 0.36%85.880.2%$174.01m
RGENRepligen Corp. 3.46%254.796.7%$161.14m
NVONovo Nordisk A/S -0.70%102.480.1%$151.83m

Company Profile

Alvotech operates as a global biopharmaceutical company, which engages in developing and manufacturing biosimilar medicines through its subsidiaries. The firm's pipeline contains biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. The company was founded on August 23, 2021 and is headquartered in Luxembourg.